DoW Lung Cancer Translational Research Award

Summary

The Department of the Army (USAMRAA) is soliciting applications for the DoW Lung Cancer Translational Research Award under the Congressionally Directed Medical Research Programs (CDMRP). This award is focused on translational research in the area of lung cancer, bridging laboratory discoveries with clinical applications. The opportunity is posted on Grants.gov and is administered by the U.S. Army Medical Research Acquisition Activity (USAMRAA). Further details on scope, eligibility, and award amounts are expected in the full program announcement.

How they evaluate

Risks & flags

• Synopsis only — full program announcement with scope, eligibility, and award value details not yet available; limited intelligence can be extracted at this stage.
• No dollar value or award ceiling disclosed, making competitive sizing impossible.
• Very long open window (05/05/2026 – 09/02/2026) is typical for CDMRP grants but the synopsis alone contains no substantive scope details.